AML With Myelodysplasia-related Features - 27 Studies Found
Recruiting |
: Characterization of the Mechanisms of Resistance to Azacitidine : Myelodysplastic Syndromes or Acute Myeloid Leukemia With Multilineage Dysplasia : 2010-09-27 |
Completed |
: Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia :
|
Completed |
: Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome :
|
Recruiting |
: Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia :
|
Completed |
: Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia :
|
Recruiting |
: Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies :
|
Recruiting |
: Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia :
: |
Recruiting |
: Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy :
: Drug: eltrombopag olamine Given PO Other Names: |
Terminated |
: Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia :
: |
Active, not recruiting |
: Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia :
: |